LINDSEY GARNETT: Open Payments
NPI 1437634987 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$932 in 31 payments from 16 companies in 2025. Trend: 2023 $498 · 2024 $1,149 · 2025 $932
Food & beverage: $932
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $257 |
| Novartis Pharmaceuticals Corporation | 4 | $94 |
| PFIZER INC. | 4 | $90 |
| Genentech USA, Inc. | 3 | $74 |
| Daiichi Sankyo Inc. | 3 | $72 |
| BeOne Medicines USA, Inc. | 2 | $52 |
| GENZYME CORPORATION | 2 | $51 |
| Merck Sharp & Dohme LLC | 2 | $40 |
| Celgene Corporation | 1 | $35 |
| JAZZ PHARMACEUTICALS INC. | 1 | $29 |
Products named: Enhertu, DATROWAY, PLUVICTO, BRUKINSA, SARCLISA, IBRANCE, KEYTRUDA, REBLOZYL.
Industry payments across IL — which companies pay providers there.
